Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02579343 · ClinicalTrials.gov registry record · NA

Adjunctive Treatment of Major Depression Utilizing Auricular Acupuncture

A NA study, sponsored by Florida Gulf Coast University.

Completed
Registry status
NA
Development phase
13
Enrollment target

NCT02579343: Completed NA study, sponsored by Florida Gulf Coast University.

NCT02579343 is a NA study that has completed, run by Florida Gulf Coast University. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02579343, a NA study, has completed, sponsored by Florida Gulf Coast University.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

This will be a randomized, single blind study of 6 weeks duration involving the use of auricular acupuncture or sham acupuncture in the adjunctive treatment of depression in college students.

Primary Outcome

Instrument developed to assess functional impairment in three inter-related domains; work/school, social and family life. Items are scored on a 0 - 10 point scale. Higher scores indicate more functional impairment.

Interventions

  • DEVICE Auricular Acupuncture
  • DRUG Sham Auricular Acupuncture + Lexapro

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2015-08
Est. Completion 2016-05
Phase NA
Florida Gulf Coast University

11 total trials

What the finished NCT02579343 record still lists

NCT02579343 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Auricular Acupuncture is the first listed.

NCT02579343 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02579343 about?

NCT02579343 is a clinical study titled "Adjunctive Treatment of Major Depression Utilizing Auricular Acupuncture". This will be a randomized, single blind study of 6 weeks duration involving the use of auricular acupuncture or sham acupuncture in the adjunctive treatment of depression in college students.

What is the current status of trial NCT02579343?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2015-08. Estimated completion is 2016-05.

What interventions are being tested in trial NCT02579343?

The interventions under investigation include: Auricular Acupuncture (DEVICE), Sham Auricular Acupuncture + Lexapro (DRUG).

Who is sponsoring clinical trial NCT02579343?

This trial is sponsored by Florida Gulf Coast University, which has 11 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02579343's enrollment target sits among peer trials

13 1911th of 2000 higher than 88 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02579343, the US trial registry maintained by the National Library of Medicine. NCT02579343 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.